Analyze Diet
Equine veterinary journal2020; 53(3); 579-589; doi: 10.1111/evj.13314

Use of in vitro assays to identify antibiotics that are cytotoxic to normal equine chondrocytes and synovial cells.

Abstract: Intra-articular (IA) antibiotic usage is prevalent in equine practice. However, recent emergence of antimicrobial resistance prompts re-evaluation of antibiotic selection, particularly when used prophylactically. Furthermore, many commonly used antibiotics exert direct cytotoxicity to equine cells, and appropriate IA doses have not been defined. Objective: To screen antibiotics in vitro as an initial assessment of cytotoxicity against normal equine joint cells in monolayer culture and explant tissues. Methods: In vitro experimental study. Methods: Chondrocytes and synovial cells were harvested from three horses and plated on 24-well plates (100 000 cells/wells in triplicate) for 48 hours prior to addition of antibiotics. Joint cells were exposed to antibiotics (n = 15) at various doses (25-0.39 mg/mL in complete DMEM media) for 24 hours and viability was assessed by trypan blue dye exclusion. The half maximal inhibitory concentration (IC50) was determined for each antibiotic. Cartilage explants were obtained from 3 horses, minced and exposed to antibiotics (n = 5) for 72 hours. Live/dead staining was performed, and fluorescence was visualised using Olympus IX83 spinning disk confocal microscope. Percentage of live vs dead cells was quantified. Results: Antibiotics from different antimicrobial classes expressed dose-dependent but variable cytotoxicity to equine joint cells in vitro. Aminoglycosides and doxycycline had the lowest IC50 (most toxic). Ampicillin sulbactam, imipenem, tobramycin, ceftiofur sodium and amoxicillin had IC50 > 25 mg/mL for at least one cell line, representing potentially less cytotoxic alternatives. Conclusions: Further studies are necessary to extrapolate these in vitro data results to the in vivo joint environment. Conclusions: Targeted IA antibiotic therapy would involve selection of the safest antibiotics (highest IC50) with efficacy based on bacterial culture/sensitivity. Antimicrobial selection and evidence-based dosing may minimise damage to native articular cartilage and synovial cells and development of antimicrobial resistance when IA antibiotics are used in equine practice.
Publication Date: 2020-07-03 PubMed ID: 32544273PubMed Central: PMC7738387DOI: 10.1111/evj.13314Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article evaluates the potential cytotoxicity of various antibiotics on equine joint cells to determine safer alternatives for intra-articular (IA) antibiotic therapy in horses. The study emphasizes the need to minimize damage to cartilage and synovial cells and combat increasing rates of antimicrobial resistance.

Methodology

  • The research involved in vitro tests with chondrocytes and synovial cells collected from three horses. These cells were grown in 24-well plates with a density of 100,000 cells per well in triplicate and cultured for 48 hours before the addition of different antibiotics.
  • A total of 15 various antibiotics at different doses (ranging from 25 – 0.39 mg/mL in complete DMEM media) were tested on joint cells in a 24-hour duration. Cell viability post-exposure was evaluated using the trypan blue dye exclusion method.
  • The level of cytotoxicity was identified by determining the concentration of each antibiotic that caused half-maximal inhibition or IC50.
  • Furthermore, cartilage explants were obtained from three horses, crushed, and exposed to five different antibiotics over 72 hours. A live/dead stain was used, and fluorescence was examined using the Olympus IX83 spinning disk confocal microscope. The number of live and dead cells was then quantified.

Findings

  • The research disclosed that antibiotics from varied antimicrobial classes showed variable, dose-dependent cytotoxicity to equine joint cells in vitro.
  • Among all, aminoglycosides and doxycycline exhibited the lowest IC50, implying these were the most toxic to the cells.
  • On the other hand, ampicillin sulbactam, imipenem, tobramycin, ceftiofur sodium, and amoxicillin showed an IC50 greater than 25 mg/mL for at least one cell line, indicating that these were less cytotoxic and thus could be safer alternatives.

Conclusions

  • The study suggests the importance of further research to relate these in vitro findings to in vivo joint environment conditions.
  • It concludes that a targeted IA antibiotic therapy should consider the safest antibiotics (those with highest IC50 levels), combined with the efficacy determined through bacterial culture and sensitivity tests.
  • By selecting suitable antibiotics and adopting evidence-based dosing, this can limit the potential damage to the cartilage and synovial cells, as well as minimizing the likelihood of antimicrobial resistance when intra-articular antibiotics are used in equine practice.

Cite This Article

APA
Pezzanite L, Chow L, Piquini G, Griffenhagen G, Ramirez D, Dow S, Goodrich L. (2020). Use of in vitro assays to identify antibiotics that are cytotoxic to normal equine chondrocytes and synovial cells. Equine Vet J, 53(3), 579-589. https://doi.org/10.1111/evj.13314

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 53
Issue: 3
Pages: 579-589

Researcher Affiliations

Pezzanite, Lynn
  • Translational Medicine Institute, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
Chow, Lyndah
  • Translational Medicine Institute, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
Piquini, Gabriella
  • Translational Medicine Institute, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
Griffenhagen, Gregg
  • Translational Medicine Institute, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
Ramirez, Dominique
  • Translational Medicine Institute, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
Dow, Steven
  • Translational Medicine Institute, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
Goodrich, Laurie
  • Translational Medicine Institute, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.

MeSH Terms

  • Animals
  • Anti-Bacterial Agents / toxicity
  • Cartilage, Articular
  • Chondrocytes
  • Horses

Grant Funding

  • TL1 TR002533 / NCATS NIH HHS
  • USDA National Institute of Food and Agriculture
  • Colorado State University Young Investigator Award in Companion Animal Studies
  • TL1TR002533 / CCTSI NIH/NCATS CTSA
  • NI18AHDR1019785G010 / Animal Health and Disease
  • Colorado State University CVMBS Veterinary Summer Scholars Program
  • Shipley Foundation
  • Verdad Foundation

Conflict of Interest Statement

Authors’ declaration of interests. The authors have no competing interests.

References

This article includes 50 references
  1. Ferris DJ, Frisbie DD, McIlwraith CW, Kawcak CE. Current joint therapy usage in equine practice: a survey of veterinarians 2009.. Equine Vet J 2011 Sep;43(5):530-5.
  2. Smith LCR, Wylie CE, Palmer L, Ramzan PHL. Synovial sepsis is rare following intrasynovial medication in equine ambulatory practice.. Equine Vet J 2019 Sep;51(5):595-599.
    pubmed: 30589107doi: 10.1111/evj.13063google scholar: lookup
  3. Gustafson SB, McIlwraith CW, Jones RL. Comparison of the effect of polysulfated glycosaminoglycan, corticosteroids, and sodium hyaluronate in the potentiation of a subinfective dose of Staphylococcus aureus in the midcarpal joint of horses.. Am J Vet Res 1989 Dec;50(12):2014-7.
    pubmed: 2610426
  4. Gustafson SB, McIlwraith CW, Jones RL, Dixon-White HE. Further investigations into the potentiation of infection by intra-articular injection of polysulfated glycosaminoglycan and the effect of filtration and intra-articular injection of amikacin.. Am J Vet Res 1989 Dec;50(12):2018-22.
    pubmed: 2610427
  5. Gillespie CC, Adams SB, Moore GE. Methods and Variables Associated with the Risk of Septic Arthritis Following Intra-Articular Injections in Horses: A Survey of Veterinarians.. Vet Surg 2016 Nov;45(8):1071-1076.
    pubmed: 27696461doi: 10.1111/vsu.12563google scholar: lookup
  6. Steel CM, Pannirselvam RR, Anderson GA. Risk of septic arthritis after intra-articular medication: a study of 16,624 injections in Thoroughbred racehorses.. Aust Vet J 2013 Jul;91(7):268-73.
    pubmed: 23782019doi: 10.1111/avj.12073google scholar: lookup
  7. Taintor J, Schumacher J, DeGraves F. Comparison of amikacin concentrations in normal and inflamed joints of horses following intra-articular administration.. Equine Vet J 2006 Mar;38(2):189-91.
    pubmed: 16536391doi: 10.2746/042516406776563233google scholar: lookup
  8. Bohannon LK, Owens SD, Walker NJ, Carrade DD, Galuppo LD, Borjesson DL. The effects of therapeutic concentrations of gentamicin, amikacin and hyaluronic acid on cultured bone marrow-derived equine mesenchymal stem cells.. Equine Vet J 2013 Nov;45(6):732-6.
    pubmed: 23448189doi: 10.1111/evj.12045google scholar: lookup
  9. Southwood LL. Perioperative antimicrobials: should we be concerned about antimicrobial drug use in equine surgical patients?. Equine Vet J 2014 May;46(3):267-9.
    pubmed: 24716707doi: 10.1111/evj.12247google scholar: lookup
  10. Amato-Gauci A, Ammon A. The First European Communicable Disease Epidemiological Report. Proceedings European Centre for Disease Prevention and Control Stockholm, Sweden, June 7, 2007.
  11. Loncaric I, Künzel F, Licka T, Simhofer H, Spergser J, Rosengarten R. Identification and characterization of methicillin-resistant Staphylococcus aureus (MRSA) from Austrian companion animals and horses.. Vet Microbiol 2014 Jan 31;168(2-4):381-7.
    pubmed: 24332703doi: 10.1016/j.vetmic.2013.11.022google scholar: lookup
  12. Theelen MJ, Wilson WD, Edman JM, Magdesian KG, Kass PH. Temporal trends in prevalence of bacteria isolated from foals with sepsis: 1979-2010.. Equine Vet J 2014 Mar;46(2):169-73.
    pubmed: 23808819doi: 10.1111/evj.12131google scholar: lookup
  13. Mallardo K, Nizza S, Fiorito F, Pagnini U, De Martino L. A comparative evaluation of methicillin-resistant staphylococci isolated from harness racing-horses, breeding mares and riding-horses in Italy.. Asian Pac J Trop Biomed 2013 Mar;3(3):169-73.
  14. Singh BR. Prevalence of vancomycin resistance and multiple drug resistance in enterococci in equids in North India.. J Infect Dev Ctries 2009 Aug 30;3(7):498-503.
    pubmed: 19762967doi: 10.3855/jidc.467google scholar: lookup
  15. Van den Eede A, Martens A, Lipinska U, Struelens M, Deplano A, Denis O, Haesebrouck F, Gasthuys F, Hermans K. High occurrence of methicillin-resistant Staphylococcus aureus ST398 in equine nasal samples.. Vet Microbiol 2009 Jan 1;133(1-2):138-44.
    pubmed: 18701224doi: 10.1016/j.vetmic.2008.06.021google scholar: lookup
  16. Van den Eede A, Hermans K, Van den Abeele A, Floré K, Dewulf J, Vanderhaeghen W, Crombé F, Butaye P, Gasthuys F, Haesebrouck F, Martens A. Methicillin-resistant Staphylococcus aureus (MRSA) on the skin of long-term hospitalised horses.. Vet J 2012 Aug;193(2):408-11.
    pubmed: 22264643doi: 10.1016/j.tvjl.2011.12.004google scholar: lookup
  17. Herdan CL, Acke E, Dicken M, Archer RM, Forsyth SF, Gee EK, Pauwels FE. Multi-drug-resistant Enterococcus spp. as a cause of non-responsive septic synovitis in three horses.. N Z Vet J 2012 Sep;60(5):297-304.
    pubmed: 22506887doi: 10.1080/00480169.2011.651702google scholar: lookup
  18. Bohlin AM, Kristoffersen M, Toft N. Infectious arthritis following intra-articular injection in horses not receiving prophylactic antibiotics: a retrospective cohort study of 2833 medical records. Proc. Am. Assoc. Equine Practnrs 2014;60:255–256.
  19. Mills ML, Rush BR, St Jean G, Gaughan EM, Mosier D, Gibson E, Freeman L. Determination of synovial fluid and serum concentrations, and morphologic effects of intraarticular ceftiofur sodium in horses.. Vet Surg 2000 Sep-Oct;29(5):398-406.
    pubmed: 10999453doi: 10.1053/jvet.2000.9141google scholar: lookup
  20. Newman JC, Prange T, Jennings S, Barlow BM, Davis JL. Pharmacokinetics of tobramycin following intravenous, intramuscular, and intra-articular administration in healthy horses.. J Vet Pharmacol Ther 2013 Dec;36(6):532-41.
    pubmed: 23531033doi: 10.1111/jvp.12048google scholar: lookup
  21. Sanchez Teran AF, Rubio-Martinez LM, Villarino NF, Sanz MG. Effects of repeated intra-articular administration of amikacin on serum amyloid A, total protein and nucleated cell count in synovial fluid from healthy horses.. Equine Vet J Suppl 2012 Dec;(43):12-6.
  22. Stover SM, Pool RR. Effect of intra-articular gentamicin sulfate on normal equine synovial membrane.. Am J Vet Res 1985 Dec;46(12):2485-91.
    pubmed: 4083580
  23. Lescun TB, Adams SB, Wu CC, Bill RP, Van Sickle DC. Effects of continuous intra-articular infusion of gentamicin on synovial membrane and articular cartilage in the tarsocrural joint of horses.. Am J Vet Res 2002 May;63(5):683-7.
    pubmed: 12013469doi: 10.2460/ajvr.2002.63.683google scholar: lookup
  24. Davenport CL, Boston RC, Richardson DW. Effects of enrofloxacin and magnesium deficiency on matrix metabolism in equine articular cartilage.. Am J Vet Res 2001 Feb;62(2):160-6.
    pubmed: 11212020doi: 10.2460/ajvr.2001.62.160google scholar: lookup
  25. Egerbacher M, Edinger J, Tschulenk W. Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture.. Am J Vet Res 2001 May;62(5):704-8.
    pubmed: 11341389doi: 10.2460/ajvr.2001.62.704google scholar: lookup
  26. Bolt DM, Ishihara A, Weisbrode SE, Bertone AL. Effects of triamcinolone acetonide, sodium hyaluronate, amikacin sulfate, and mepivacaine hydrochloride, alone and in combination, on morphology and matrix composition of lipopolysaccharide-challenged and unchallenged equine articular cartilage explants.. Am J Vet Res 2008 Jul;69(7):861-7.
    pubmed: 18593234doi: 10.2460/ajvr.69.7.861google scholar: lookup
  27. Sanders WE Jr, Sanders CC. Toxicity of antibacterial agents: mechanism of action on mammalian cells.. Annu Rev Pharmacol Toxicol 1979;19:53-83.
  28. Chang Y, Goldberg VM, Caplan AI. Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells.. Clin Orthop Relat Res 2006 Nov;452:242-9.
  29. Parker RA, Clegg PD, Taylor SE. The in vitro effects of antibiotics on cell viability and gene expression of equine bone marrow-derived mesenchymal stromal cells.. Equine Vet J 2012 May;44(3):355-60.
  30. Pezzanite L, Chow L, Soontararak S, Phillips J, Goodrich L, Dow S. Amikacin induces rapid dose-dependent apoptotic cell death in equine chondrocytes and synovial cells in vitro.. Equine Vet J 2020 Sep;52(5):715-724.
    doi: 10.1111/evj.13243pubmed: 31997397google scholar: lookup
  31. McIlwraith CW, Frisbie DD, Kawcak CE, Fuller CJ, Hurtig M, Cruz A. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the horse.. Osteoarthritis Cartilage 2010 Oct;18 Suppl 3:S93-105.
    pubmed: 20864027doi: 10.1016/j.joca.2010.05.031google scholar: lookup
  32. Rasband WS. Image J. U.S. National Institutes of Health 1997–2018, Bethesda, Maryland, USA.
  33. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis.. Nat Methods 2012 Jul;9(7):671-5.
    pmc: PMC5554542pubmed: 22930834doi: 10.1038/nmeth.2089google scholar: lookup
  34. Abramoff MD, Magalhaes PJ, Ram SJ. Image Processing with ImageJ. Biophotonics International 2004;11:36–42.
  35. Mahlberg K, Krootila K, Uusitalo R. Compatibility of corticosteroids and antibiotics in combination.. J Cataract Refract Surg 1997 Jul-Aug;23(6):878-82.
    pubmed: 9292672doi: 10.1016/s0886-3350(97)80247-7google scholar: lookup
  36. Firth EC, Klein WR, Nouws JF, Wensing T. Effect of induced synovial inflammation on pharmacokinetics and synovial concentration of sodium ampicillin and kanamycin sulfate after systemic administration in ponies.. J Vet Pharmacol Ther 1988 Mar;11(1):56-62.
  37. Errecalde JO, Carmely D, Mariño EL, Mestorino N. Pharmacokinetics of amoxycillin in normal horses and horses with experimental arthritis.. J Vet Pharmacol Ther 2001 Feb;24(1):1-6.
  38. Dowling PM. Antimicrobial therapy. Equine Clinical Pharmacology 2004;pp 13–48.
  39. Gilbertie JM, Schaer TP, Schubert AG, Jacob ME, Menegatti S, Ashton Lavoie R, Schnabel LV. Platelet-rich plasma lysate displays antibiofilm properties and restores antimicrobial activity against synovial fluid biofilms in vitro.. J Orthop Res 2020 Jun;38(6):1365-1374.
    pmc: PMC8018705pubmed: 31922274doi: 10.1002/jor.24584google scholar: lookup
  40. Wuelling M, Vortkamp A. Cartilage explant cultures.. Methods Mol Biol 2014;1130:89-97.
    pubmed: 24482167doi: 10.1007/978-1-62703-989-5_7google scholar: lookup
  41. Byron CR, Trahan RA. Comparison of the Effects of Interleukin-1 on Equine Articular Cartilage Explants and Cocultures of Osteochondral and Synovial Explants.. Front Vet Sci 2017;4:152.
    pmc: PMC5611359pubmed: 28979900doi: 10.3389/fvets.2017.00152google scholar: lookup
  42. Orsini JA, Soma LR, Rourke JE, Park M. Pharmacokinetics of amikacin in the horse following intravenous and intramuscular administration.. J Vet Pharmacol Ther 1985 Jun;8(2):194-201.
  43. Sedrish SA, Moore RM, Barker SA. Pharmacokinetics of single dose intra-articular administration of amikacin in the radiocarpal joints of normal horses. Proceedings of the American College of Veterinary Surgeons Meeting 1994;Chicago, Illinois; p 437.
  44. Lloyd KC, Stover SM, Pascoe JR, Baggot JD, Kurpershoek C, Hietala S. Plasma and synovial fluid concentrations of gentamicin in horses after intra-articular administration of buffered and unbuffered gentamicin.. Am J Vet Res 1988 May;49(5):644-9.
    pubmed: 2840005
  45. Werner LA, Hardy J, Bertone AL. Bone gentamicin concentration after intra-articular injection or regional intravenous perfusion in the horse.. Vet Surg 2003 Nov-Dec;32(6):559-65.
  46. Whiteside LA, Roy ME, Nayfeh TA. Intra-articular infusion: a direct approach to treatment of infected total knee arthroplasty.. Bone Joint J 2016 Jan;98-B(1 Suppl A):31-6.
    pubmed: 26733638doi: 10.1302/0301-620x.98b.36276google scholar: lookup
  47. Peppers MP, Whiteside LA, Lazear RM, Roy ME. Vancomycin injected in the knee achieved high synovial fluid concentration with a half-life of 3.4 hours. Proceedings, Orthopedic Research Society 2011;pp1567.
  48. Whiteside LA, Roy ME. One-stage Revision With Catheter Infusion of Intraarticular Antibiotics Successfully Treats Infected THA.. Clin Orthop Relat Res 2017 Feb;475(2):419-429.
    pmc: PMC5213931pubmed: 27511201doi: 10.1007/s11999-016-4977-ygoogle scholar: lookup
  49. Antoci V Jr, Adams CS, Hickok NJ, Shapiro IM, Parvizi J. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro.. Clin Orthop Relat Res 2007 Sep;462:200-6.
    pubmed: 17572634doi: 10.1097/blo.0b013e31811ff866google scholar: lookup
  50. Dogan M, Isyar M, Yilmaz I, Bilir B, Sirin DY, Cakmak S, Mahirogullari M. Are the leading drugs against Staphylococcus aureus really toxic to cartilage?. J Infect Public Health 2016 May-Jun;9(3):251-8.
    pubmed: 26603270doi: 10.1016/j.jiph.2015.10.004google scholar: lookup

Citations

This article has been cited 1 times.
  1. Pezzanite L, Chow L, Hendrickson D, Gustafson DL, Russell Moore A, Stoneback J, Griffenhagen GM, Piquini G, Phillips J, Lunghofer P, Dow S, Goodrich LR. Evaluation of Intra-Articular Amikacin Administration in an Equine Non-inflammatory Joint Model to Identify Effective Bactericidal Concentrations While Minimizing Cytotoxicity.. Front Vet Sci 2021;8:676774.
    doi: 10.3389/fvets.2021.676774pubmed: 34095281google scholar: lookup